大博医疗（002901）1月27日主力资金净买入1299.83万元

Core Viewpoint - The stock of Dabo Medical (002901) has shown a significant increase, with a closing price of 51.9 yuan on January 27, 2026, reflecting a rise of 7.45% [1] Group 1: Stock Performance - On January 27, 2026, Dabo Medical's trading volume was 72,400 hands, with a total transaction amount of 371 million yuan [1] - The net inflow of main funds was 12.99 million yuan, accounting for 3.51% of the total transaction amount, while retail investors experienced a net outflow of 3.12 million yuan, representing 0.84% of the total transaction amount [1] Group 2: Financing and Margin Trading - On January 27, 2026, the financing buy amounted to 24.87 million yuan, while financing repayment was 29.06 million yuan, resulting in a net repayment of 4.19 million yuan [2] - The margin trading balance stood at 142 million yuan [2] Group 3: Financial Performance - For the first three quarters of 2025, Dabo Medical reported a main revenue of 1.876 billion yuan, a year-on-year increase of 22.69%, and a net profit attributable to shareholders of 425 million yuan, up 77.03% year-on-year [3] - In Q3 2025, the company achieved a single-quarter main revenue of 666 million yuan, reflecting a year-on-year increase of 17.82%, and a net profit of 180 million yuan, which is a 77.49% increase year-on-year [3] - The company's gross profit margin was reported at 71.23% [3]